HCP life science innovation ApS: Financial statements 2023
CVR: 40003665
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
HCP life science innovation ApS (CVR 40003665) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -513,540 and a net result of DKK -206,233 compared with DKK -470,213 the year before. Equity in the 2023 report amounted to DKK 261,719. The solvency ratio was 17.6%.
- Gross Profit
- DKK -513,540
- Profit/Loss
- DKK -206,233
- Equity
- DKK 261,719
- Total Assets
- DKK 1,486,433
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -514K | -206K | 262K | - |
| 2022 | - | -471K | -470K | 118K | - |
| 2021 | - | -590K | -509K | 88K | - |
| 2020 | - | -201K | -199K | 97K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout HCP life science innovation ApS
HCP life science innovation ApS is a Danish company of the type Anpartsselskab based in Brande, founded in 2018. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Hans-Christoph Paul. The company is owned by HCP HOLDING ApS. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK 9,955 and a net result of DKK 34,931 compared with DKK -123,484 the year before. Equity in the 2026 report amounted to DKK 150,057.
